Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Seminal bacteria can lower sperm quality in subfertile men.

Multiple plasma donations do not change donors' biochemical parameters.

Some patients fail bladder function tests due to lower flow rates and higher remaining urine volumes, but the exact reasons for failure are unclear.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Researchers established normal hair and scalp characteristics for healthy women using trichoscopy.

PRGF treatments increased hair number and thickness in people with hair loss, with more injections leading to better results.

People with hair loss may have worse urinary symptoms due to an enlarged prostate.

Women of child-bearing age with androgenic alopecia lose hair density, especially in certain areas, and their hair becomes thinner. They also lose more than twice as much hair as healthy women.

Using a special laser and growth serum can safely increase hair thickness and density in people with hair loss.

PRP therapy significantly improves hair growth and density in men with androgenic alopecia.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

A new hair restoration technology was found to effectively increase hair thickness, density, and growth, while reducing hair loss and improving scalp health, with no side effects.

PRP shows promise for treating hair loss, but more research is needed.

HA-stimulated stem cell vesicles improved hair growth in male mice with androgenetic alopecia.

PRP therapy with specific growth factors improves hair density and thickness in androgenic alopecia.

More research is needed to understand how skin type affects laser treatment for hair loss.

People with hair loss have different hormone levels, and these hormones can affect hair growth.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Ultrasound boosts finasteride's hair growth effects in mice.

Severe and early hair loss may indicate a higher risk of heart disease.